FACTANKER · measured, cited, anchored official records connected

SEC EDGAR CompanyFacts fact · reporting period

ANTIVIRAL TECHNOLOGIES, INC.: interest_expense

One fact, its scope and the complete path back to the official record.

Period: 2007-09-13 – 2013-12-31Status: currentProvenance attached

Cite: FACTANKER, https://factanker.com/fact/b63ea0d3-188d-4b69-b29b-62660e371b9b

Reported value

$-31.962k{"amount": -31962, "concept": "us-gaap:InterestExpense", "currency": "USD"}
Entity
ANTIVIRAL TECHNOLOGIES, INC.
Metric
interest_expense
Period
2007-09-13 – 2013-12-31
Status
current
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0001137050-14-000058 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-08-19T14:16:15.007057+02:00
Raw response SHA-256f7bde1a401b286c74a2fd824ee1df541…
Official-identifier pathhttps://factanker.com/fact/sec/cik-0001445226/interest-expense/2013-12-31 (CIK, metric, reporting date)
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.